Oval’s platforms offer the ability to deliver a wide range of drug formulations for both subcutaneous and intramuscular injection. With the ability to customise each of our platforms to the needs of your formulation, partnering with Oval means precisely tailored autoinjectors to meet your brief.
Alongside our platforms, Oval also offer drug device combinations to partner, taking our advanced technologies and combining them with a drug to offer a package tailored to the patient’s needs.
Oval’s cyclic olefin primary drug containers offer a range of benefits over traditional glass based designs. These include greater design flexibility, accurate and consistent drug delivery, and a more robust package that contains fewer potential contaminants.